Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, Kevin Tuballes, Juan Manuel Carreño, Sammita Satyanarayan, Susan Filomena, Erin Staker, Johnstone Tcheou, Aaron Miller, Michelle Fabian, Neha Safi, Jamie Nichols, Jasmin Patel, Stephen Krieger, Stephanie Tankou, Sam Horng, Sylvia Klineova, Erin Beck, Miriam Merad, Fred Lublin
doi: https://doi.org/10.1101/2022.06.10.22276253
Ilana Katz Sand
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDSacha Gnjatic
2Precision Immunology Institute, Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029
3Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029
4Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029
PhDFlorian Krammer
4Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029
5Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA
PhDKevin Tuballes
2Precision Immunology Institute, Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029
Juan Manuel Carreño
5Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA
Sammita Satyanarayan
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDSusan Filomena
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
BAErin Staker
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
BSJohnstone Tcheou
5Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA
Aaron Miller
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDMichelle Fabian
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDNeha Safi
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDJamie Nichols
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDJasmin Patel
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDStephen Krieger
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDStephanie Tankou
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MD, PhDSam Horng
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MD, PhDSylvia Klineova
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDErin Beck
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MD, PhDMiriam Merad
2Precision Immunology Institute, Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY 10029
3Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MD, PhDFred Lublin
1Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Department of Neurology, Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, NY 10029
MDData Availability
All data produced in the present study are available upon reasonable request to the authors and as allowed by institutional regulations
Posted June 14, 2022.
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, Kevin Tuballes, Juan Manuel Carreño, Sammita Satyanarayan, Susan Filomena, Erin Staker, Johnstone Tcheou, Aaron Miller, Michelle Fabian, Neha Safi, Jamie Nichols, Jasmin Patel, Stephen Krieger, Stephanie Tankou, Sam Horng, Sylvia Klineova, Erin Beck, Miriam Merad, Fred Lublin
medRxiv 2022.06.10.22276253; doi: https://doi.org/10.1101/2022.06.10.22276253
Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy
Ilana Katz Sand, Sacha Gnjatic, Florian Krammer, Kevin Tuballes, Juan Manuel Carreño, Sammita Satyanarayan, Susan Filomena, Erin Staker, Johnstone Tcheou, Aaron Miller, Michelle Fabian, Neha Safi, Jamie Nichols, Jasmin Patel, Stephen Krieger, Stephanie Tankou, Sam Horng, Sylvia Klineova, Erin Beck, Miriam Merad, Fred Lublin
medRxiv 2022.06.10.22276253; doi: https://doi.org/10.1101/2022.06.10.22276253
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (628)
- Anesthesia (165)
- Cardiovascular Medicine (2381)
- Dermatology (207)
- Emergency Medicine (380)
- Epidemiology (11777)
- Forensic Medicine (10)
- Gastroenterology (703)
- Genetic and Genomic Medicine (3751)
- Geriatric Medicine (350)
- Health Economics (635)
- Health Informatics (2401)
- Health Policy (933)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (366)
- Medical Ethics (105)
- Nephrology (398)
- Neurology (3510)
- Nursing (198)
- Nutrition (528)
- Oncology (1825)
- Ophthalmology (538)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (233)
- Palliative Medicine (66)
- Pathology (446)
- Pediatrics (1035)
- Primary Care Research (420)
- Public and Global Health (6149)
- Radiology and Imaging (1280)
- Respiratory Medicine (828)
- Rheumatology (379)
- Sports Medicine (323)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (146)